Early Treatment with Monoclonal Antibodies

Monoclonal antibodies (mAb) are lab-made antibodies that act as substitutes for the ones our bodies naturally create to fight infections. Under an Emergency Use Authorization (EUA), the FDA has authorized the use of several mAb treatments to help people with current COVID-19 infections who are at high risk. For some patients, mAb treatment can help reduce worsening symptoms and avoid hospitalization. mAb treatments may reduce the amount of virus in the body, leading to milder COVID-19 symptoms and quicker recovery.

Monoclonal antibodies (mAb) are lab-made antibodies that act as substitutes for the ones our bodies naturally create to fight infections. Under an Emergency Use Authorization (EUA), the FDA has authorized the use of several mAb treatments to help people with current COVID-19 infections who are at high risk. For some patients, mAb treatment can help reduce worsening symptoms and avoid hospitalization. mAb treatments may reduce the amount of virus in the body, leading to milder COVID-19 symptoms and quicker recovery.

mAb treatments work best when given soon after COVID-19 infection. Healthcare providers administer the treatments at infusion centers so they can perform the infusion and monitor any reactions. Find out if you and your doctor should consider mAb treatment and locate an infusion center near you today.

mAb treatments work best when given soon after COVID-19 infection. Healthcare providers administer the treatments at infusion centers so they can perform the infusion and monitor any reactions. Find out if you and your doctor should consider mAb treatment and locate an infusion center near you today.

Have questions or need help? Call 1-(877)-332-6585.

Have questions or need help? Call 1-(877)-332-6585.